Matches in Wikidata for { <http://www.wikidata.org/entity/Q71059806> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q71059806 description "artículu científicu espublizáu en mayu de 1996" @default.
- Q71059806 description "im Mai 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71059806 description "scientific article published on 01 May 1996" @default.
- Q71059806 description "wetenschappelijk artikel" @default.
- Q71059806 description "наукова стаття, опублікована в травні 1996" @default.
- Q71059806 name "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 name "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 type Item @default.
- Q71059806 label "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 label "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 prefLabel "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 prefLabel "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 P1433 Q71059806-DD5C3383-5816-46AC-AE03-E2AC7F2EA89C @default.
- Q71059806 P1476 Q71059806-878F83BA-16A1-4294-95C0-E843DF6FA4FA @default.
- Q71059806 P2093 Q71059806-02277132-7E1F-4A49-A02B-66161AF748B4 @default.
- Q71059806 P2093 Q71059806-415758D5-85EA-4533-ABF8-63D992431F90 @default.
- Q71059806 P2093 Q71059806-5793BAD0-6E83-4949-94DA-2EFCD6BE0C8D @default.
- Q71059806 P2093 Q71059806-842344AC-5708-4CDF-A224-D87D04841097 @default.
- Q71059806 P2093 Q71059806-DC5E80F8-2BC2-4C5D-A65A-256244170ABF @default.
- Q71059806 P304 Q71059806-BCB84061-92AB-4F32-B43E-3601650BCC73 @default.
- Q71059806 P31 Q71059806-AAB6CA15-46FB-4467-B942-F763BA35AB64 @default.
- Q71059806 P356 Q71059806-18AAA1BC-022B-408B-B244-B7598C074113 @default.
- Q71059806 P407 Q71059806-A80E148A-C934-4178-BE6E-92BC2E4381B7 @default.
- Q71059806 P433 Q71059806-7E764A41-8D65-40A7-8819-0C3B941AAE92 @default.
- Q71059806 P478 Q71059806-A41AA2BF-D920-41F4-807A-FD907EB03E67 @default.
- Q71059806 P50 Q71059806-64926C2D-BC87-4DDC-81B9-0E214A041BA9 @default.
- Q71059806 P50 Q71059806-C9E265E3-5FE3-4E58-BA76-2F34A83088E0 @default.
- Q71059806 P577 Q71059806-DA696CEF-DD67-4988-80BF-D8569A65DF62 @default.
- Q71059806 P698 Q71059806-AB405869-1A38-4DFB-AE68-C0633DB26080 @default.
- Q71059806 P921 Q71059806-028E9DF6-3546-4498-AB2F-02D39447270F @default.
- Q71059806 P356 JCO.1996.14.5.1581 @default.
- Q71059806 P698 8622075 @default.
- Q71059806 P1433 Q400292 @default.
- Q71059806 P1476 "Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients" @default.
- Q71059806 P2093 "A Freijs" @default.
- Q71059806 P2093 "J Bergh" @default.
- Q71059806 P2093 "M L Fjällskog" @default.
- Q71059806 P2093 "M O Karlsson" @default.
- Q71059806 P2093 "M Sandström" @default.
- Q71059806 P304 "1581-1588" @default.
- Q71059806 P31 Q13442814 @default.
- Q71059806 P356 "10.1200/JCO.1996.14.5.1581" @default.
- Q71059806 P407 Q1860 @default.
- Q71059806 P433 "5" @default.
- Q71059806 P478 "14" @default.
- Q71059806 P50 Q66206118 @default.
- Q71059806 P50 Q66206609 @default.
- Q71059806 P577 "1996-05-01T00:00:00Z" @default.
- Q71059806 P698 "8622075" @default.
- Q71059806 P921 Q238512 @default.